Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 367.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 11.50 (3.142%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 367.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

End of the Programme & 9 - 28 Nov Transactions

26 Nov 2021 12:05

RNS Number : 7595T
Banco Santander S.A.
26 November 2021
 

Banco Santander, S.A., in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

End of the Buy-back Programme

Reference is made to our notice of inside information of 6 October, 2021 (official registry number 1086) relating to the buyback programme of own shares (the "Buy-back Programme" or the "Programme") approved by the Board of Directors of Banco Santander, S.A. (the "Company" or "Banco Santander"). Banco Santander informs that, after the last acquisitions mentioned below, the maximum investment provided for in the Buy-back Programme, i.e. 841 million euros was reached, implying the acquisition of a total of 259,930,273 own shares, representing approximately 1.499% of the Company's share capital. The acquisition of shares under the Buy-back Programme has been communicated on a regular basis, pursuant to the provisions of article 2.2 and 2.3 of the Commission Delegated Regulation (EU) No. 2016/1052. The Buy-back Programme has therefore been terminated as a consequence of the above and in accordance with the terms set out when it was announced.

As disclosed when the Buy-back Programme was launched, its purpose was to reduce the Bank's share capital by redeeming the shares acquired under the Buy-back Programme in a capital reduction expected to be submitted for approval at the 2022 Ordinary General Shareholders' Meeting.

Last transactions executed under the Programme. 

Moreover, pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Company informs -on the basis of the information received from Morgan Stanley Europe SE as intermediary in charge of executing the Buy-back Programme- that the transactions executed as part of the Buy-back Programme, between 19 and 25 November 2021 (both included) were as follows:

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

19/11/2021

SAN.MC

Purchase

XMAD

9,695,299

€3.0698

22/11/2021

SAN.MC

Purchase

XMAD

10,249,680

€3.0835

23/11/2021

SAN.MC

Purchase

XMAD

10,426,600

€3.0790

24/11/2021

SAN.MC

Purchase

XMAD

10,655,100

€3.0712

25/11/2021

SAN.MC

Purchase

XMAD

9,157,731

€3.0526

TOTAL

50,184,410

 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

 

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

 

Detailed information of the transactions carried out within the referred period is attached as Annex I.

Boadilla del Monte (Madrid), 26 November 2021

 

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 19th and 25th November, 2021 (both included)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBDBDBXGDDGBL
Date   Source Headline
26th Oct 20177:00 amRNS3Q2017 results report, presentation & charts
25th Oct 20173:02 pmRNS3Q2017 results presentation
17th Oct 20174:54 pmRNSDirector/PDMR Shareholding
17th Oct 20174:54 pmRNSDirector/PDMR Shareholding
17th Oct 20174:54 pmRNSDirector/PDMR Shareholding
17th Oct 20174:53 pmRNSDirector/PDMR Shareholding
17th Oct 20174:52 pmRNSDirector/PDMR Shareholding
17th Oct 20177:00 amRNSInformation on Santander Dividendo Elección
10th Oct 20174:45 pmRNSConcluding Remarks Executive Chairman - GSU
10th Oct 20174:16 pmRNSCFO - Group Strategy Update
10th Oct 20173:47 pmRNSMEXICO - Group Strategy Update
10th Oct 20173:32 pmRNSUS - Group Strategy Update
10th Oct 20173:17 pmRNSBRAZIL - Group Strategy Update
10th Oct 20172:48 pmRNSSPAIN - Group Strategy Update
10th Oct 20172:29 pmRNSUK - Group Strategy Update
10th Oct 20171:26 pmRNSCEO - Group Strategy Update
10th Oct 201712:56 pmRNSPress release - Group Strategy Update
10th Oct 201712:54 pmRNSExecutive Chairman - Group Strategy Update
9th Oct 20173:35 pmRNSMeeting with analysts and investors
29th Sep 201710:41 amRNSPost-Stabilisation Notice - Santander AT1
26th Sep 20175:13 pmRNSPreferred securities contingently convertible
26th Sep 20178:49 amRNSSantander AT1 Pre-Stabilisation Notice
12th Sep 20173:25 pmRNSFidelity Bonds: Approval and registration
24th Aug 201712:57 pmRNSDirector/PDMR Shareholding
8th Aug 20174:45 pmRNSAgreement between Banco Popular & Blackstone Fund
1st Aug 20176:24 pmRNSDirector/PDMR Shareholding
1st Aug 20176:11 pmRNSDirector/PDMR Shareholding
1st Aug 20176:10 pmRNSDirector/PDMR Shareholding
1st Aug 20176:07 pmRNSDirector/PDMR Shareholding
1st Aug 20176:07 pmRNSDirector/PDMR Shareholding
1st Aug 20176:05 pmRNSDirector/PDMR Shareholding
1st Aug 20176:05 pmRNSDirector/PDMR Shareholding
1st Aug 20176:04 pmRNSDirector/PDMR Shareholding
1st Aug 20176:02 pmRNSDirector/PDMR Shareholding
1st Aug 20176:01 pmRNSDirector/PDMR Shareholding
1st Aug 20176:01 pmRNSDirector/PDMR Shareholding
1st Aug 20176:00 pmRNSDirector/PDMR Shareholding
1st Aug 20175:59 pmRNSDirector/PDMR Shareholding
1st Aug 20175:58 pmRNSDirector/PDMR Shareholding
1st Aug 20175:58 pmRNSDirector/PDMR Shareholding
1st Aug 20175:56 pmRNSDirector/PDMR Shareholding
1st Aug 20175:55 pmRNSDirector/PDMR Shareholding
1st Aug 20175:54 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSInformation on Santander Dividendo Eleccion
28th Jul 20174:40 pmRNSAdmission to listing of the new shares
28th Jul 20177:00 amRNS1H2017 results report, presentation & charts
28th Jul 20177:00 amRNS1st half 2017 results press release
27th Jul 20174:40 pmRNSCapital increase: Amendment of the floor price
27th Jul 20174:38 pmRNSCapital increase: Closing and registration
27th Jul 20173:31 pmRNS1st half 2017 results presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.